| Literature DB >> 28906151 |
Daniel J Denmark1, Robert H Hyde1, Charlotte Gladney1,2, Manh-Huong Phan1, Kirpal S Bisht3, Hariharan Srikanth1, Pritish Mukherjee1, Sarath Witanachchi1.
Abstract
Conventional therapeutic techniques treat patients by delivering biotherapeutics to the entire body. With targeted delivery, biotherapeutics are transported to the afflicted tissue reducing exposure to healthy tissue. Targeted delivery devices are minimally composed of a stimuli responsive polymer allowing triggered release and magnetic nanoparticles enabling targeting as well as alternating magnetic field (AMF) heating. Although more traditional methods, like emulsion polymerization, have been used to realize such devices, the synthesis is problematic. For example, surfactants preventing agglomeration must be removed from the product increasing time and cost. Ultraviolet (UV) photopolymerization is more efficient and ensures safety by using biocompatible substances. Reactants selected for nanogel fabrication were N-isopropylacrylamide (monomer), methylene bis-acrylamide (crosslinker), and Irgacure 2959 (photoinitiator). The 10 nm superparamagnetic nanoparticles for encapsulation were composed of iron oxide. Herein, a low-cost, scalable, and rapid, custom-built UV photoreactor with in situ, spectroscopic monitoring system is used to observe synthesis. This method also allows in situ encapsulation of the magnetic nanoparticles simplifying the process. Nanogel characterization, performed by transmission electron microscopy, reveals size-tunable nanogel spheres between 40 and 800 nm in diameter. Samples of nanogels encapsulating magnetic nanoparticles were subjected to an AMF and temperature increase was observed indicating triggered release is possible. Results presented here will have a wide range of applications in medical sciences like oncology, gene delivery, cardiology, and endocrinology.Entities:
Keywords: Magnetic nanoparticles; induction heating; photopolymerization; stimuli–responsive polymer; targeted biotherapeutic delivery
Mesh:
Substances:
Year: 2017 PMID: 28906151 PMCID: PMC8241111 DOI: 10.1080/10717544.2017.1373164
Source DB: PubMed Journal: Drug Deliv ISSN: 1071-7544 Impact factor: 6.419
Figure 1.(a) Schematic and (b) photograph of experimental apparatus for photopolymerization synthesis of PNIPAM nanogels and in-situ monitoring.
Nomenclature of the precursor solution recipes investigated to demonstrate PNIPAM nanogel size control.
| Sample | Dilution | NIPAM | MBA | Irgacure 2959 |
|---|---|---|---|---|
| 1.0R1 | 1.0 | 3 | 1 | 1 |
| 0.5R1 | 0.5 | 3 | 1 | 1 |
| 0.1R1 | 0.1 | 3 | 1 | 1 |
| 1.0R2 | 1.0 | 10 | 1 | 1 |
| 0.5R2 | 0.5 | 10 | 1 | 1 |
| 1.0R3 | 1.0 | 1 | 1 | 1 |
Figure 2.(a) A typical precursor solution, containing monomer, crosslinker, and photoinitiator dispersed in filtered DIW, before and after almost 35 min of UV exposure. (b) TEM of PNIPAM nanogels synthesized via UV exposure having an average size of approximately 200 nm as shown by the inset particle size distribution. (c) Intensity of the UV source as a function of elapsed exposure time quantifying the attenuation of the UV source. (d) Results of the precursor solution concentration study for demonstration of nanogel size control. This dilution study of average PNIPAM nanogel average size versus monomer to crosslinker ratio reveals that dilution leads to smaller nanogels and higher crosslinker content with respect to monomer leads to larger nanogels.
Figure 3.(a) Photographs of the precursor solution 1.0R3 with 0.2 mg mL−1 IOMNPs dispersed therein before and after being exposed to the UV source for about 35 min. (b) The transmittance of the UV source through the sample photographed in (a) as a function of elapsed exposure time. (c) TEM of the PNIPAM nanogels synthesized, in the presence of IOMNPs, via UV exposure. (d) A particle size distribution of the nanogels shown in (c) revealing an average size of approximately 1000 nm.
Figure 4.(a) The sample was agitated after UV exposure, thereby suspending bare IOMNPs, empty nanogels, and PNIPAM embedded IOMNPs in the water column. (b) Bare IOMNPs settle relatively fast under the influence of gravity. A static magnetic field can be made to isolate embedded IOMNPs, from the empty nanogels and bare IOMNPs, along the cuvette wall.
Figure 5.(a) The AMF heating curves of the sample comprised of precursor solution 1.0R3 and IOMNPs after being exposed to the UV source. (b) The SAR as a function of the square of the applied magnetic field amplitude.